A Dutch startup called myTomorrows has raised a total of $6 million to develop a platform connecting patients, doctors and drugmakers to give patients with life-threatening diseases access to drugs still in the development stage. "We allow doctors and biotech companies to help patients with unmet medical needs, given the complicated nature of providing access to development-stage drugs," myTomorrows chief financial officer Erdem Yavuz said.

Full Story:

Related Summaries